Moderna and CARsgen team up on CAR-T cell therapy and mRNA cancer vaccine combo

Katherine Lewin

News Reporter

CARsgen will test its Claudin18.2 CAR T-cell candidate, dubbed CT041, in combination with Moderna’s investigational mRNA cancer vaccine in a collaboration …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Moderna and CARsgen team up on CAR-T cell therapy and mRNA cancer vaccine combo

Katherine Lewin

News Reporter

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

Gardasil demand in China sinks, and Merck expects the same next quarter

‘Imitation is best form of flattery’: Regeneron CEO comments on Amgen’s Eylea biosimilar

UCB's anti-tau Alzheimer's program fails Phase 2 primary endpoint, but highlights positive secondaries

Amgen makes pipeline cuts, but obesity plans remain the focus

AbbVie adds to T cell engager momentum, with EvolveImmune pact starting at $65M

Q&A: Jade CEO talks about reverse merger and IgAN drugs

Mod­er­na and CARs­gen team up on CAR-T cell ther­a­py and mR­NA can­cer vac­cine com­bo

News Reporter

Sign up to read this article for free.

more like this

Viridian Therapeutics

Waltham, MA, USA

Moderna and CARsgen team up on CAR-T cell therapy and mRNA cancer vaccine combo